Faculty of Public Health, Khon Kaen University, Khon Kaen, Thailand.
Departments of Internal Medicine/Cardiology, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal.
Kathmandu Univ Med J (KUMJ). 2021;19(76):474-480.
Background Since prehistoric time to the earlier 20th century, diabetes was accounted as comorbidity among tuberculosis patients, which is reducing the treatment efficiency. Objective To investigate the prevalence and determinants of type 2 diabetes mellitus among tuberculosis patients in central development region of Nepal. Method An analytical cross-sectional study was conducted by using structured questionnaire. Face to face interview as well as reviewing of the medical records of the tuberculosis cases has been performed during September 2018 - February 2019. The systematic random sampling was applied to select 306 tuberculosis cases. Then the respondents were examined for blood glucose level as well as Glycated haemoglobin (HbA1c) level to identify TB with Diabetes Mellitus. The proportion of respondents with fasting blood glucose level ≥ 126 mg/dl or a random blood glucose ≥ 200 mg/dl was considered as Tuberculosis with Diabetes Mellitus cases. Similarly, haemoglobin A1C ≥ 7% was accessed as amplified risk for tuberculosis. Multiple logistic regression was performed to analyse the factors associated with Tuberculosis with Diabetes Mellitus by using STATA. P value < 0.05 was taken as statistically significant. Result A total of 306 tuberculosis patients were included in the study. The mean ± standard deviation of age of participants was 36.82±15.94 years. The proportion of male slightly exceeded than that of female with a ratio of 1.73:1. The prevalence of TBDM was 17.32% (95% CI: 13.05-21.58) of all diagnosed tuberculosis cases. Our multivariable analysis identified the factors those were associated with TBDM were age ≥ 45 years (adj.OR=3.97, 95% CI 1.81-8.71, p value 0.001), patients residing in the urban areas (adj.OR=9.75, 95% CI 1.99-47.6, p value 0.005), had Body Mass Index (BMI) < 18.5 Kg/m2 (adj.OR=3.20, 95% CI 1.58-6.51, p value 0.001), had diastolic blood pressure ≥ 80 mmHg (adj.OR=2.34, 95% CI 1.17-4.66, p value 0.015) and patients who were treated with Cat II and Cat III tuberculosis treatment regimens (adj.OR=2.65, 95% CI 1.22-5.73, p value 0.013). Conclusion The prevalence of type 2 diabetes mellitus among tuberculosis patients was higher than prevalence of diabetes in general population of Nepal and it was higher among male, urban residents, patients with low BMI and the older aged tuberculosis patients.
背景 自史前时代到 20 世纪初,糖尿病一直被认为是结核病患者的合并症之一,这降低了治疗效率。目的 研究尼泊尔中部发展地区结核病患者中 2 型糖尿病的患病率及其决定因素。方法 采用结构问卷进行分析性横断面研究。2018 年 9 月至 2019 年 2 月期间,对结核病患者进行了面对面访谈和病历回顾。采用系统随机抽样选择了 306 例结核病患者。然后检查受访者的血糖水平和糖化血红蛋白(HbA1c)水平,以确定是否患有糖尿病合并结核病。空腹血糖水平≥126mg/dl 或随机血糖水平≥200mg/dl 的受访者比例被认为是糖尿病合并结核病病例。同样,血红蛋白 A1C≥7%被视为结核病的风险增加。使用 STATA 进行多变量逻辑回归分析,以确定与糖尿病合并结核病相关的因素。P 值<0.05 被认为具有统计学意义。结果 共纳入 306 例结核病患者。参与者的平均年龄±标准差为 36.82±15.94 岁。男性略多于女性,比例为 1.73:1。所有确诊结核病病例中糖尿病合并结核病的患病率为 17.32%(95%CI:13.05-21.58)。我们的多变量分析确定了与 TBDM 相关的因素包括年龄≥45 岁(调整后 OR=3.97,95%CI 1.81-8.71,p 值 0.001)、居住在城市地区(调整后 OR=9.75,95%CI 1.99-47.6,p 值 0.005)、体重指数(BMI)<18.5kg/m2(调整后 OR=3.20,95%CI 1.58-6.51,p 值 0.001)、舒张压≥80mmHg(调整后 OR=2.34,95%CI 1.17-4.66,p 值 0.015)和接受 Cat II 和 Cat III 结核病治疗方案的患者(调整后 OR=2.65,95%CI 1.22-5.73,p 值 0.013)。结论 结核病患者中 2 型糖尿病的患病率高于尼泊尔一般人群中糖尿病的患病率,且男性、城市居民、BMI 较低和年龄较大的结核病患者患病率更高。